137 related articles for article (PubMed ID: 21042320)
61. Acute myeloid leukaemia: recent data on prognostic gene mutations, in relation to stratified therapies for elderly patients.
Soura EN; Karikas GA
J BUON; 2019; 24(4):1326-1339. PubMed ID: 31646775
[TBL] [Abstract][Full Text] [Related]
62. TET2 mutation in diffuse large B-cell lymphoma.
Kubuki Y; Yamaji T; Hidaka T; Kameda T; Shide K; Sekine M; Kamiunten A; Akizuki K; Shimoda H; Tahira Y; Nakamura K; Abe H; Miike T; Iwakiri H; Tahara Y; Sueta M; Yamamoto S; Hasuike S; Nagata K; Kitanaka A; Shimoda K
J Clin Exp Hematop; 2017; 56(3):145-149. PubMed ID: 28331128
[TBL] [Abstract][Full Text] [Related]
63. Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.
Yamazaki J; Taby R; Jelinek J; Raynal NJ; Cesaroni M; Pierce SA; Kornblau SM; Bueso-Ramos CE; Ravandi F; Kantarjian HM; Issa JP
J Natl Cancer Inst; 2015 Nov; 108(2):. PubMed ID: 26568194
[TBL] [Abstract][Full Text] [Related]
64. Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia.
Wang J; He N; Wang R; Tian T; Han F; Zhong C; Zhang C; Hua M; Ji C; Ma D
Sci Rep; 2020 Feb; 10(1):2706. PubMed ID: 32066746
[TBL] [Abstract][Full Text] [Related]
65. Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome.
Robinson HM; Broadfield ZJ; Cheung KL; Harewood L; Harris RL; Jalali GR; Martineau M; Moorman AV; Taylor KE; Richards S; Mitchell C; Harrison CJ
Leukemia; 2003 Nov; 17(11):2249-50. PubMed ID: 14523475
[No Abstract] [Full Text] [Related]
66. Venetoclax induced complete remission in extramedullary relapse of AML co-harboring
Pan W; Zhao X; Shi W; Jiang Z; Xiao H
Leuk Lymphoma; 2020 Nov; 61(11):2756-2759. PubMed ID: 33167720
[No Abstract] [Full Text] [Related]
67. Reassessment of loss of heterozygosity within MLL in childhood acute lymphoblastic leukemia.
van Schooten CJ; Ellis LM; Morison IM
Blood; 2003 May; 101(10):4222; author reply 4222-3. PubMed ID: 12732503
[No Abstract] [Full Text] [Related]
68. [Individualized treatment of leukemia patients by monitoring of minimal residual disease (MRD) based on WT1 assay].
Ogawa H; Sugiyama H
Rinsho Ketsueki; 1998 Feb; 39(2):107-8. PubMed ID: 9545812
[No Abstract] [Full Text] [Related]
69. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
[TBL] [Abstract][Full Text] [Related]
70. INI-1, a partner gene of ALL-1, is highly conserved in human acute leukemia.
Mimori K; Inoue H; Ishii H; Mori M
Oncol Rep; 2003; 10(3):551-3. PubMed ID: 12684622
[TBL] [Abstract][Full Text] [Related]
71. FLT3 mutations in childhood acute lymphoblastic leukemia.
Armstrong SA; Mabon ME; Silverman LB; Li A; Gribben JG; Fox EA; Sallan SE; Korsmeyer SJ
Blood; 2004 May; 103(9):3544-6. PubMed ID: 14670924
[TBL] [Abstract][Full Text] [Related]
72. Mutational screen reveals a novel JAK2 mutation, L611S, in a child with acute lymphoblastic leukemia.
Kratz CP; Böll S; Kontny U; Schrappe M; Niemeyer CM; Stanulla M
Leukemia; 2006 Feb; 20(2):381-3. PubMed ID: 16341038
[No Abstract] [Full Text] [Related]
73. AML1 amplification in a case of childhood acute lymphoblastic leukemia.
Morel F; Herry A; Le Bris MJ; Douet-Guilbert N; Le Calvez G; Marion V; Berthou C; De Braekeeler M
Cancer Genet Cytogenet; 2002 Sep; 137(2):142-5. PubMed ID: 12393286
[TBL] [Abstract][Full Text] [Related]
74. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
Cimmino L; Dolgalev I; Wang Y; Yoshimi A; Martin GH; Wang J; Ng V; Xia B; Witkowski MT; Mitchell-Flack M; Grillo I; Bakogianni S; Ndiaye-Lobry D; Martín MT; Guillamot M; Banh RS; Xu M; Figueroa ME; Dickins RA; Abdel-Wahab O; Park CY; Tsirigos A; Neel BG; Aifantis I
Cell; 2017 Sep; 170(6):1079-1095.e20. PubMed ID: 28823558
[TBL] [Abstract][Full Text] [Related]
75. Potential role for wild-type p53 in leukemias with MLL gene translocations.
Megonigal MD; Rappaport EF; Nowell PC; Lange BJ; Felix CA
Oncogene; 1998 Mar; 16(10):1351-6. PubMed ID: 9546437
[TBL] [Abstract][Full Text] [Related]
76. RAS mutations in pediatric leukemias with MLL gene rearrangements.
Mahgoub N; Parker RI; Hosler MR; Close P; Winick NJ; Masterson M; Shannon KM; Felix CA
Genes Chromosomes Cancer; 1998 Mar; 21(3):270-5. PubMed ID: 9523205
[TBL] [Abstract][Full Text] [Related]
77. The overexpression of KIT proto-oncogene in acute leukemic cells is not necessarily caused by the gene mutation.
Szatkowski D; Hellmann A
Acta Haematol; 2015; 133(1):116-23. PubMed ID: 25247397
[TBL] [Abstract][Full Text] [Related]
78. Analysis of MYH Tyr165Cys and Gly382Asp variants in childhood leukemias.
Akyerli CB; Ozbek U; Aydin-Sayitoğlu M; Sirma S; Ozçelik T
J Cancer Res Clin Oncol; 2003 Oct; 129(10):604-5. PubMed ID: 12920580
[No Abstract] [Full Text] [Related]
79. Characterization of t(12;21) breakpoint junctions in acute lymphoblastic leukemia.
Andersen MT; Nordentoft I; Hjalgrim LL; Christiansen CL; Jakobsen VD; Hjalgrim H; Pallisgaard N; Madsen HO; Christiansen M; Ryder LP; Clausen N; Hokland P; Schmiegelow K; Melbye M; Jørgensen P
Leukemia; 2001 May; 15(5):858-9. PubMed ID: 11368451
[No Abstract] [Full Text] [Related]
80. Pediatric Acute Lymphoblastic Leukemia With Hypereosinophilia and IDH2 Gene Mutation: A Case Report and Literature Review.
Gho DS; Cooper RM
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e546-e549. PubMed ID: 34966098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
